Mirtazapine Tablet, Film Coated
Product Images NDC 55154-0280

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 55154-0280). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

15mg Bag Label (7a5545a0 4dbb 48ac B0d2 477a8dd4b87e 00)

Label for Mirtazapine tablets, USP 15 mg, film-coated, round scored tablets with 'M' over '515' debossed on one side. Pack contains 10 tablets. Manufactured for Mylan Pharmaceuticals Inc., distributed by Safecor Health LLC and Cardinal Health. Includes storage instructions and a warning that the unit dose package is not child resistant and is intended for institutional use only.*

FDA Label Image

Mirtazapine Structural Formula (Image 04)

Chemical structure diagram of Mirtazapine, showing the arrangement of its nitrogen-containing rings and methyl group as part of its molecular framework.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.